Full-Time

Associate / Senior Associate

Aiml, Pioneering Intelligence Origination

Posted on 1/13/2025

Flagship Pioneering

Flagship Pioneering

201-500 employees

Biotechnology firm creating health and sustainability solutions

Food & Agriculture
Biotechnology
Healthcare

Mid, Senior

Cambridge, MA, USA

Category
Applied Machine Learning
AI Research
AI & Machine Learning
Required Skills
LLM
Data Science
Data Structures & Algorithms
Machine Learning
Reinforcement Learning

You match the following Flagship Pioneering's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • PhD or equivalent in Computer Science, Data Science, Machine Learning, or other technical fields
  • 2+ years of experience in post-doc, tech, or a related tech-centered industry preferred
  • Experience working in an entrepreneurial environment and demonstrated passion for entrepreneurship
  • Hands-on experience developing/building technically challenging projects
  • Experienced with algorithms such as LLM, diffusion model, reinforcement learning, causal inference preferred
  • Excellent analytical and problem-solving skills
  • Excellent communication skills, across verbal, written and PowerPoint presentation
  • Ability to navigate complex information, relentlessly prioritize, and thoughtfully handle ambiguity
  • A passion for innovation and a willingness to explore uncharted territories
Responsibilities
  • Lead Flagship-model explorations to rapidly ideate interesting areas of innovation where AI/ML and computation can create outsized impact, and develop novel, actionable and high value venture hypotheses
  • Perform computational proof-of-concept experiments to de-risk/enable/refine venture hypotheses
  • Research competitive landscape, formulate initial strategy and operational plan, and develop pitch for new venture creation alongside a Principal or Partner on the venture creation team
  • Lead development team (internal or external) on daily research and platform building
  • Work closely with Flagship operations team (Finance, IP, IT, HR, etc.) to oversee day-to-day company operation, and play project management role across development team and stakeholders
  • Proactively manage operational and strategic risks, including but not limited to identifying what proof-of-concept studies to conduct in what sequence to de-risk the technology, anticipating potential technical hurdles and pre-emptively seeking support, translating emerging results into strategic implications
  • Define and evolve value-creation opportunity, including interacting with internal and external stakeholders to develop product-market fit, alongside a Principal or Partner
  • Clearly communicate progress and risks to Flagship leadership on regular basis
  • Stay up to date on the latest technology development and novel applications in AI/ML and other technical areas of focus across therapeutic and general use cases
  • Contribute to team building efforts, including but not limited to mentoring summer fellows, contributing to defining overall strategy for Pioneering Intelligence, liaising with internal computational scientists on knowledge sharing and additional research topics
Desired Qualifications
  • 2+ years of experience in post-doc, tech, or a related tech-centered industry preferred
  • Experienced with algorithms such as LLM, diffusion model, reinforcement learning, causal inference preferred

Flagship Pioneering fosters a culture of groundbreaking advancements in biotechnology, emphasizing an ecosystem approach that synergizes human health and sustainability. Their business model not only focuses on creating transformative products but also incubates leading companies like Moderna and Indigo Agriculture, positioning them at the forefront of scientific innovation and industry leadership. This approach offers employees a unique opportunity to be part of a pioneering team that drives real-world impacts across multiple sectors.

Company Size

201-500

Company Stage

N/A

Total Funding

$10.2B

Headquarters

Cambridge, Maryland

Founded

2000

Simplify Jobs

Simplify's Take

What believers are saying

  • Flagship's collaboration with Cambridge institutes accelerates biotech research and innovation.
  • Strategic partnerships with Pfizer enhance Flagship's capabilities in cardiometabolic and cancer treatments.
  • Flagship's focus on AI-driven platforms aligns with growing trends in drug discovery.

What critics are saying

  • Over-reliance on strategic partners like Pfizer could impact Flagship's projects.
  • Rapid valuation increases may pressure Flagship to deliver similar results across its portfolio.
  • High-profile executive appointments could lead to internal power dynamics and strategic disagreements.

What makes Flagship Pioneering unique

  • Flagship Pioneering creates first-in-category ventures transforming health and sustainability.
  • The company combines science, entrepreneurialism, and capital management for systematic innovation.
  • Flagship's evolutionary methodology navigates from unreasonable propositions to transformational outcomes.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Flexible Work Hours

Company News

PR Newswire
Jan 23rd, 2025
Flagship Pioneering, Cambridge University Health Partners, And Milner Therapeutics Institute Announce Collaboration To Accelerate Biotech Research And Innovation

First of its Kind Scientific Collaboration Will Engage Top Research Institutes in Cambridge, UK with Flagship PioneeringFocus on Scaling and Advancing Flagship's Breakthrough Science and Technologies through the Cambridge Life Sciences EcosystemLONDON, Jan. 23, 2025 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, today announced an agreement with top life science organisations Cambridge University Health Partners (CUHP) and the Milner Therapeutics Institute (MTI) to collaborate to jointly advance breakthrough scientific research and technologies

Genetic Engineering & Biotechnology News
Jan 8th, 2025
Novo Nordisk, Valo Health Ink Expanded Up-to-$4.6B AI Collaboration

The following year, Flagship Pioneering formally announced the launch of privately-held Valo, joining with other undisclosed investors to bring the company's total financing to nearly $100 million.

Bloomberg
Jan 7th, 2025
Ag Tech Startup Inari Gets $2.17 Billion Valuation in Latest Funding Round

Massachusetts agtech startup Inari Agriculture Inc. said it raised $144 million of new equity at a $2.17 billion valuation, a roughly 32% jump from a prior mark of $1.65 billion set last January.

Contract Pharma
Nov 21st, 2024
Flagship Pioneering Enters Agreements Under Strategic Pfizer Pact

Flagship Pioneering, a bioplatform company, entered agreements with Ampersand Biomedicines and Montai Therapeutics to identify targeted molecules that could be further developed as treatments for obesity and non-small cell lung cancer (NSCLC).

PR Newswire
Nov 20th, 2024
Flagship Pioneering Announces Two New Agreements With Ampersand Biomedicines And Montai Therapeutics Under Its Strategic Partnership With Pfizer

Ampersand's AND™ Platform will be used to identify programmed biologics for the treatment of obesity-related targets. Montai's CONECTA™ AI platform will be used to identify small molecules directed to a potential Non-Small Cell Lung Cancer-related target. Collaborations will leverage Pfizer's deep expertise in early discovery and development for cardiometabolic and cancer treatments, two priority therapeutic areas for the company

Endpoints News
Nov 20th, 2024
Exclusive: Former Pfizer commercial chief Angela Hwang to join Flagship

Former Pfizer exec Angela Hwang is joining Flagship Pioneering as a CEO-partner and chief executive of its startup Metaphore Biotechnologies on Jan. 1, the incubator...

PR Newswire
Nov 13th, 2024
Flagship Pioneering Appoints Craig Williams As Ceo-Partner And Chief Executive Officer Of Apriori Bio

Williams was promoted from Operating Partner at Flagship Pioneering and President at Apriori BioApriori Bio has made significant progress in 2024, including securing a collaboration with CEPI, assembling a world class board of directors and building out an early pipeline of prospective vaccinesCAMBRIDGE, Mass., Nov. 13, 2024 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, and Apriori Bio, a biotechnology company aimed at providing humanity with variant-resilient protection against rapidly-evolving viruses, today announced that Craig Williams, MBA, has been promoted to CEO-Partner at Flagship Pioneering and Chief Executive Officer of Apriori

CityBiz
Nov 13th, 2024
Flagship Pioneering Appoints Craig Williams as CEO-Partner and Chief Executive Officer of Apriori Bio

Flagship Pioneering, the bioplatform innovation company, and Apriori Bio, a biotechnology company aimed at providing humanity with variant-resilient protection against rapidly-evolving viruses, today announced that Craig Williams, MBA, has been promoted to CEO-Partner at Flagship Pioneering and Chief Executive Officer of Apriori.

CityBiz
Oct 23rd, 2024
Flagship Pioneering Appoints Junaid Bajwa as Senior Partner, Head of United Kingdom,

Flagship Pioneering, the bioplatform innovation company, today announced that Junaid Bajwa, M.D., has joined its London office as Senior Partner and Head of United Kingdom.

INACTIVE